Kenneth Carl Anderson - 02 Jan 2026 Form 4 Insider Report for C4 Therapeutics, Inc. (CCCC)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
05 Jan 2026, 16:10:46 UTC
Prior SEC filing
03 Oct 2025
Next SEC filing
03 Apr 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jolie M. Siegel, Attorney-in-Fact
Filing notes and source

Key filing fact

Kenneth Carl Anderson filed Form 4 for C4 Therapeutics, Inc. (CCCC) on 05 Jan 2026.

Key facts

  • This page summarizes Kenneth Carl Anderson's Form 4 filing for C4 Therapeutics, Inc. (CCCC).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 05 Jan 2026, 16:10.

Change

  • Previous filing in this sequence was filed on 03 Oct 2025.
  • Current net transaction value: +$11,499.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001824862 Primary reporting owner

Anderson Kenneth Carl

Relationship
Director
Address
C/O C4 THERAPEUTICS, INC., 490 ARSENAL WAY #120, WATERTOWN
Signature
/s/ Jolie M. Siegel, Attorney-in-Fact
Signature date
05 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CCCC transaction

Common Stock

Award

Transaction value
$11,499
Shares
+5,958
Change %
+4.2%
Price
$1.93
Shares after
146,532
Date
02 Jan 2026
Ownership
Direct
Footnotes
F1, F2
CCCC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
47,316
Date
02 Jan 2026
Ownership
By Spouse
CCCC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
61,265
Date
02 Jan 2026
Ownership
By Kenneth C. Anderson 2016 Grantor Retained Annuity Trust
Footnotes
F3
CCCC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
61,265
Date
02 Jan 2026
Ownership
By Cynthia E. Anderson 2016 Grantor Retained Annuity Trust
Footnotes
F4
CCCC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
16,939
Date
02 Jan 2026
Ownership
By Kenneth C. Anderson 2015 Irrevocable Trust
Footnotes
F5
CCCC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
16,939
Date
02 Jan 2026
Ownership
By Cynthia E. Anderson 2015 Irrevocable Trust
Footnotes
F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer.

Footnote F2

The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on January 2, 2026.

Footnote F3

Shares held by the Kenneth C. Anderson 2016 Grantor Retained Annuity Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Footnote F4

Shares held by the Cynthia E. Anderson 2016 Grantor Retained Annuity Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Footnote F5

Shares held by the Kenneth C. Anderson 2015 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Footnote F6

Shares held by the Cynthia E. Anderson 2015 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

SEC remarks

Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .